COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?

References

1. 1.↵
   2. Wu Y,
   3. Xu X,
   4. Chen Z, et al

   . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18–22 doi:10.1016/j.bbi.2020.03.031 pmid:32240762

   CrossRefPubMed
2. 2.↵
   2. Li YC,
   3. Bai WZ,
   4. Hashikawa T

   . The neuroinvasive potential of SARS-COV-2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92;552–55 doi:10.1002/jmv.25728 pmid:32104915

   CrossRefPubMed
3. 3.↵
   2. Chen T,
   3. Wu D,
   4. Chen H, et al

   . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091 doi:10.1136/bmj.m1091 pmid:32217556

   Abstract/FREE Full Text
4. 4.↵
   2. Poyiadji N,
   3. Shahin G,
   4. Noujaim D, et al

   . COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020 Mar 31. [Epub ahead of print] doi:10.1148/radiol.2020201187 pmid:32228363

   CrossRefPubMed
5. 5.↵
   2. Rossi A

   . Imaging of acute disseminated encephalomyelitis. Neuroimaging Clin N Am 2008;18:149–61 doi:10.1016/j.nic.2007.12.007 pmid:18319160

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Starkey J,
   3. Kobayashi N,
   4. Numaguchi Y, et al

   . Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics 2017;37:562–76 doi:10.1148/rg.2017160085 pmid:28165876

   CrossRefPubMed
7. 7.↵
   2. Miller AH,
   3. Haroon E,
   4. Raison CL, et al

   . Cytokine targets in the brain: impact on neurotransmitter and neurocircuits. Depress Anxiety 2013;30:297–306 doi:10.1002/da.22084 pmid:23468190

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Phelps C,
   3. Korneva E, et al

   . Neuroimmune biology. Cytokines and the Brain. Vol 6. Elsevier; 2008:295–98
9. 9.↵
   2. Leonoudakis D,
   3. Braithwaite SP,
   4. Beattie MS, et al

   . TNFa-induced AMPA-receptor trafficking in CNS neurons: relevance to excitotoxicity? Neuron Glia Biol 2004;1:263–73 doi:10.1017/S1740925X05000608 pmid:16520832

   CrossRefPubMed
10. 10.↵
    2. Prow NA,
    3. Irani DN

    . The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis. J Neurochem 2008;105:1276–86 doi:10.1111/j.1471-4159.2008.05230.x pmid:18194440

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Matute C,
    3. Alberdi E,
    4. Domercq M, et al

    . Excitotoxic damage to white matter. J Anat 2007;210:693–702 doi:10.1111/j.1469-7580.2007.00733.x pmid:17504270

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Hassel B,
    3. Boldingh KA,
    4. Narvesen C, et al

    . Glutamate transport, glutamate synthetase and phosphate-activated glutaminase in rat CNS white matter: a quantitative study. J Neurochem 2003;87:230–37 doi:10.1046/j.1471-4159.2003.01984.x pmid:12969269

    CrossRefPubMed
13. 13.↵
    2. Domercq M,
    3. Matute C

    . Expression of glutamate transporters in adult bovine corpus callosum. Brain Res Mol Brain Res 1999;67:296–302 doi:10.1016/S0169-328X(99)00072-8 pmid:10216228

    CrossRefPubMed
14. 14.↵
    2. Goursaud S,
    3. Kozlova EN,
    4. Maloteaux J-M, et al

    . Cultured astrocytes derived from corpus callosum or cortical grey matter show distinct glutamate handling properties. J Neurochem 2009;108:1442–52 doi:10.1111/j.1471-4159.2009.05889.x pmid:19222709

    CrossRefPubMed
15. 15.↵
    2. Moritani T,
    3. Smoker WR,
    4. Sato Y, et al

    . Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR Am J Neuroradiology 2005;26:216–28 pmid:15709116

    FREE Full Text
16. 16.↵
    2. Takayama H,
    3. Kobayashi M,
    4. Sugishita M, et al

    . Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury. Clin Neurol Neurosurg 2000;102:135–39 doi:10.1016/S0303-8467(00)00079-2 pmid:10996710

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Kimura EN,
    3. Okamoto S,
    4. Uchida Y, et al

    . A reversible lesion of the corpus callosum splenium with adult influenza-associated encephalitis/encephalopathy: a case report. J Med Case Rep 2008;2:220 doi:10.1186/1752-1947-2-220 pmid:18588700

    CrossRefPubMed
18. 18.↵
    2. Yang LI,
    3. Huang YN,
    4. Cui ZT

    . Clinical features of acute corpus callosum infarction patients. Int J Clin Exp Pathol 2014;7:5160–64 pmid:25197390

    PubMed
19. 19.↵
    2. Tang N,
    3. Bai H,
    4. Chen X, et al

    . Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094–99 doi:10.1111/jth.14817 pmid:32220112

    CrossRefPubMed